Related Experiment Video
Updated: Jul 4, 2026

Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster
Published on: March 12, 2018
Understanding the nature of prion diseases using cell-free assays
1Department of Pathology and Mental Health Research Institute of Victoria, University of Melbourne, Melbourne, Australia.
Abstract:
A central event in the transmission and pathogenesis of transmissible spongiform encephalopathy diseases is the misfolding of the prion protein. Considerable progress has been made in our understanding of this misfolding event through the development of cell-free assays that mimic the molecular features of prion propagation. This chapter reviews the contribution of cell-free assays to our understanding of prion propagation.
Insights
Cell-free assays have significantly advanced our understanding of prion protein misfolding, a key event in transmissible spongiform encephalopathy diseases. These methods mimic prion propagation, aiding research into disease mechanisms.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative diseases.
- Prion protein (PrP) misfolding is central to TSE pathogenesis and transmission.
- Understanding PrP misfolding is crucial for developing therapeutic strategies.
Purpose of the Study:
- To review the critical role of cell-free assays in elucidating prion propagation.
- To highlight how these assays model the molecular mechanisms of prion formation.
Main Methods:
- The chapter focuses on the application and findings derived from cell-free prion propagation systems.
- These assays replicate key biochemical and biophysical aspects of PrP misfolding in vitro.
Main Results:
- Cell-free systems have provided invaluable insights into the kinetics and co-factor requirements of prion formation.
- They have enabled detailed biochemical characterization of the structural changes during PrP conversion.
Conclusions:
- Cell-free assays are indispensable tools for studying prion diseases.
- Continued development and application of these systems will further unravel TSE pathogenesis.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Subviral Agents

